| Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2012: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2011: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
|---|
| Research Abstract |
Hypereosinophilic syndrome (HES) is a heterogeneous disorders characterized by prolonged eosinophilia with causes unknown. We clarified the clinical differential diagnosis of the patients who participated in this study, and tested for the existence of FIP1L1-PDGFRA chimeric mRNA by RT-PCR. Moreover, we also performed phosphoproteomic studies by mass spectrometry (nanoLC-MS/MS) using the phsphopeptides extracted from peripheral blood of various patients and found the different profiles with which correlate the underlying condition of eosinophilia. This information of phosphopeptides could be useful in the differential diagnosis of HES.
|
